§ 33-56-3. Company Action Level Events; Preparation and Submission of Risk-Based Capital Level Plan; Hearing; Out-of-State Filing
As used in this Code section, “company action level event” means any of the following events: The filing of an RBC report by an insurer which indicates that: The insurer’s total adjusted capital is greater than or equal to its regulatory action level RBC but less than its company action level RBC; If a life […]
§ 33-53-2. Conditions of Coverage
An insurance policy that provides coverage for drugs may not exclude coverage of a covered drug on the grounds that the drug has not been approved by the federal Food and Drug Administration for the particular indication if any of the following conditions are met: The drug is recognized for treatment of the indication in […]
§ 33-56-4. Regulatory Action Level Events; Preparation and Submission of Risk-Based Capital Level Plan; Determination of Corrective Actions; Hearing; Expenses
For the purposes of this Code section, “regulatory action level event” means, with respect to any insurer, any of the following events: The filing of an RBC report by the insurer which indicates that the insurer’s total adjusted capital is greater than or equal to its authorized control level RBC but less than its regulatory […]
§ 33-53-4. Exceptions to Requirements for Coverage
This chapter shall not be deemed to do any of the following: Require coverage for any drug when the federal Food and Drug Administration has determined the drug’s use to be contraindicated; Require coverage for an experimental drug not approved for any indication by the federal Food and Drug Administration; Alter any other law limiting […]
§ 33-56-5. Authorized Control Level Events; Actions by Commissioner
For the purposes of this Code section, “authorized control level event” means any of the following events: The filing of an RBC report by the insurer which indicates that the insurer’s total adjusted capital is greater than or equal to its mandatory control level RBC but less than its authorized control level RBC; The notification […]
§ 33-54-1. Legislative Findings and Determinations; Intent of Chapter
The General Assembly finds and determines that recent advances in genetic science have led to improvements in the diagnosis, treatment, and understanding of a significant number of human diseases. The General Assembly further finds and declares that: Genetic information is the unique property of the individual tested; The use and availability of information concerning an […]
§ 33-56-6. Mandatory Control Level Events; Actions by Commissioner
For purposes of this Code section, “mandatory control level event” means any of the following events: The filing of an RBC report which indicates that the insurer’s total adjusted capital is less than its mandatory control level RBC; Notification by the Commissioner to the insurer of an adjusted RBC report that indicates the event in […]
§ 33-54-2. Definitions
As used in this chapter, the term: “Genetic testing” means laboratory tests of human DNA or chromosomes for the purpose of identifying the presence or absence of inherited alterations in genetic material or genes which are associated with a disease or illness that is asymptomatic at the time of testing and that arises solely as […]
§ 33-54-3. Purpose of Testing; Consent Required; Confidential and Privileged Information
Except as otherwise provided in this chapter, genetic testing may only be conducted to obtain information for therapeutic or diagnostic purposes. Genetic testing may not be conducted without the prior written consent of the person to be tested. Information derived from genetic testing shall be confidential and privileged and may be released only to the […]
§ 33-54-4. Prohibited Use of Information
Any insurer that receives information derived from genetic testing may not use the information for any nontherapeutic purpose. History. Code 1981, § 33-54-4 , enacted by Ga. L. 1995, p. 1242, § 4.